Clinical Trial

An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

Name: An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease — clinical trial record (NCT07279844)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Trial Details

NCT Number	NCT07279844
Lead Sponsor	Anhui Provincial Hospital
Conditions	Parkinson's Disease
Enrollment	6 participants
Start Date	2025-12-15
Primary Completion	2029-12-14 (estimated)
Study Completion	2029-12-14 (estimated)
Updated on ClinicalTrials.gov	2025-12-12